FREE Case Review (866) 588-0600

Roundup Linked to Liver Disease: Study

A new study has found that glyphosate, the active ingredient in Roundup weed killer, causes non-alcoholic fatty liver disease in laboratory rats at very low doses.

A new study has found that glyphosate, the active ingredient in Roundup weed killer, causes non-alcoholic fatty liver disease (NAFLD) in laboratory rats at very low doses.

Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with non-Hodgkin’s lymphoma after using or being exposed to Roundup weed killer, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against Monsanto and our lawyers can help.

What’s the problem?

January 10, 2017 – The study, published Monday in the journal Scientific Reports, used cutting edge profiling methods to analyze the molecular composition of the livers of female rats that were given extremely low doses of Roundup herbicide (thousands of times lower than what is permitted by health regulators worldwide) over a 2-year period.

The results indicated that these animals developed non-alcoholic fatty liver disease (NAFLD). According to the researchers, this study is unique in that it is the first to show a causative link between the consumption of Roundup and a serious disease.

“The findings of our study are very worrying as they demonstrate for the first time a causative link between an environmentally relevant level of Roundup consumption over the long-term and a serious disease – namely non-alcoholic fatty liver disease,” said Dr Michael Antoniou of King’s College London, lead author of the study. “Our results also suggest that regulators should reconsider the safety evaluation of glyphosate-based herbicides.”

The study indicates that long-term consumption of an ultra-low dose of Roundup at a glyphosate intake level of just 4 nanograms per kilogram of body weight per day — which is 437,500 times below levels permitted in the U.S. — results in NAFLD.

Health regulators accept toxicity studies in rats as an indicator of potential human health risks. Therefore, the new study’s findings may have serious consequences for human health, according to the researchers.

Non-alcoholic fatty liver disease currently affects about 25% of the U.S. population. Risk factors include being overweight or obese, having diabetes, high cholesterol or high triglycerides in the blood. Rapid weight loss and poor eating habits also may lead to the disease.

Symptoms of NAFLD include:

  • Fatigue
  • Weakness
  • Weight loss
  • Loss of appetite
  • Nausea
  • Abdominal pain
  • Spider-like blood vessels
  • Yellowing of the skin and eyes (jaundice)
  • Itching
  • Fluid buildup and swelling of the legs (edema) and abdomen (ascites)
  • Mental confusion

If left untreated, non-alcoholic fatty liver disease can progress to the more serious condition non-alcoholic steatohepatitis (NASH).

Do I have a Roundup Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Roundup lawsuits. We are handling individual litigation nationwide and currently accepting new cancer cases in all 50 states.

Free Case Evaluation: Again, if you got non-Hodgkin’s lymphoma from Roundup, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition